SEC Form 4 · accession 0000899243-16-028966
Aldeyra Therapeutics, Inc. · ALDX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard Douglas
Director
Period of report
Sep 13, 2016
Accepted (ET)
Sep 14, 2016 · 4:45 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001341235
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $5.62 | Sep 13, 2016 | A | 12,166 | A | — | Sep 12, 2026 | Common Stock | 12,166 | 12,166 | D |
Explanation of responses
- F1Exercisable in equal annual installments over three years of continuous service to the Issuer after September 13, 2016.